Announcement • Jun 19
BPLATS,Inc. to Report Q1, 2027 Results on Aug 10, 2026 BPLATS,Inc. announced that they will report Q1, 2027 results on Aug 10, 2026 Announcement • Jun 16
BPLATS,Inc. announced that it has received ¥2.20561 million in funding from Growth Partners Co., Ltd. On June 15, 2026, BPLATS,Inc. closed the transaction. The company issued 20,051 series 7 stock acquisition rights at an issue price of ¥110 for gross proceeds of ¥2,205,610. The initial exercise price is ¥371. The exercise period is from June 16, 2026 to June 15, 2030. The transaction will happen through third party allocation. New Risk • Jun 09
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-JP¥448m). Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (JP¥785.9m market cap, or US$4.91m). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Revenue is less than US$5m (JP¥727m revenue, or US$4.5m).